Searchable abstracts of presentations at key conferences in endocrinology

ea0063p625 | Diabetes, Obesity and Metabolism 2 | ECE2019

Features of IL-17 expression in focus of inflammation modulating in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

Kondratiuk Kateryna , Kondratiuk Valentyna , Lysianyj Mykola , Mykhalchyschyn Galyna

According to recent views, underlying cause and characteristic of type 2 diabetes mellitus (DM2), complicated by non-alcoholic fatty liver disease (NAFLD) is chronic systemic low-gradient inflammation, in which the leading role in liver damage and DM2 decompensation is given to the cytokine production. The purpose of this study was to compare the levels of interleukin 17 (IL-17) expression in patients with DM2 and NAFLD, as well as to assess the relationship between IL-17 and ...